Trials And tribulations Of Being Director Of The NIH

The past few months have been difficult ones for the National Institutes of Health and its director, James B. Wyngaarden. A series of public controversies has rocked the institution, tarnishing what many regard as the crown jewel of the federal scientific establishment. The Department of Health and Human Services, which oversees NIH, removed Edwin Becker as head of NIH’S Office of Research Services for “inefficiency and mismanagement,” despite strong opposition from Wyngaard


Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

The past few months have been difficult ones for the National Institutes of Health and its director, James B. Wyngaarden. A series of public controversies has rocked the institution, tarnishing what many regard as the crown jewel of the federal scientific establishment. The Department of Health and Human Services, which oversees NIH, removed Edwin Becker as head of NIH’S Office of Research Services for “inefficiency and mismanagement,” despite strong opposition from Wyngaarden and his top staff The Office of Management and Budget insisted that NIH reduce the proportion of the more than 3,000 intramural managers and scientific staff on NIH’S Bethesda campus who receive outstanding performance citations— and the salary raises that accompany them—and reclassify downward some staffers so cited. And House subcommittees held two contentious hearings on fraud in biomedical science and NIH’S role in controlling it.

The 63-year-old Wyngaarden became NIH director in 1982, after establishing an enviable ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio